Pre-congress sessions will be day-long courses for those interested in specific topics. There is no additional cost to attend these sessions, but it will be required to reserve a spot to secure a seat. Download full list of pre-congress sessions.
Pre-congress Session I: Fundamentals of PD (Simultaneous translation into French)
Pre-congress Session II: Interdisciplinary Care & Parkinson's Disease
Pre-congress Session III: Science & Advocacy
Tuesday, October 1, 2013
Pre-congress Session I : Fundamentals of PD
Target Audience: Non-clinicians, people with Parkinson’s, others
participants to key topics that will be elaborated on in the program. Give them a glimpse of what is to come and
tools to get the most out of the meeting. Introduce the role of PwPs into the
meeting design and success as well as the legacy of the WPC.
- To gain a basic understanding of Parkinson’s,
including the research into the cause(s) of the disease, symptoms, and
- To learn the spectrum of care and rehabilitation
options once diagnosed with Parkinson’s;
- To understand future therapies for Parkinson’s.
9:15AM Introduction Tom Isaacs (UK)
9:30AM What is PD? Stanley Fahn (USA)
of PD Dennis
causes PD? Marie-Francoise
& A Panel Facilitator: David
features Ronald Pfeiffer (USA)
& A Panel Facilitator:
David Iverson (USA)
1:15PM What you can do after you are diagnosed to stay involved Peter Davison (Canada)
1:30PM Therapeutic options to stay active and involved
- Speech and Parkinson’s Bonnie
- Physical therapy and Parkinson’s Terry Ellis (USA)
- Occupational therapy and Parkinson’s Margarita Makoutonina (Australia)
2:15PM Q & A Panel Facilitator: Linda Morgan (USA)
3:00PM Future therapies
- Stem cells Patrik
- Viral vectors and gene therapy Jeffrey Kordower (USA)
- Drug treatments Olivier
3:50PM Q & A Panel Facilitator:
Linda Morgan (USA)
3:55PM Getting the most out of the WPC 2013 Bob Kuhn (Canada)
4:05 PM Wrap-up Bob Kuhn (Canada) & Stanley
Pre-congress Session II : Interdisciplinary Care &
Target Audience: Allied health professionals, members of
multidisciplinary teams, health professionals interested in interdisciplinary
Goal: The aim of
this pre-congress course is to provide a forum for discussion of service
delivery models in PD. Current model types will be presented for the purpose of
discussion and will be referenced to a template of current service delivery
components. The ideal model should focus on the complexity of PD, the need to
provide continuity of care and be able to deal with the cumulative morbidities
associated with a chronic illness.
- Understand the complexity of PD and its underlying
- Be aware of the wide variety of factors that need
to be considered in providing comprehensive and continuous care;
- Be able to advise on the development, modification
or redesign of a service model for PD taking into consideration the
organizational infrastructure of the delegate’s institution.
9:00AM Introduction Anne-Louise Lafontaine (Canada)
9:10AM What do we face? Bastiaan
9:40AM How is it addressed? &
of available delivery options & models currently in use Ruth Hagestuen (USA)
10:10AM What this all means for people with
Parkinson’s Alice Templin (Canada)
11:00AM Introduction Mark Guttman (Canada)
The role of the Multidisciplinary Team: Evidence that shows
it is working and what UNIQUE contribution these people make to the team.
11:20AM General practitioner’s role Christiane Lepage (Canada)
11:40AM Geriatrician’s role Peter Fletcher
12:00PM Nurse’s role Lucie
12:20PM Rehabilitation team’s role Meg Morris (Australia)
12:40PM - 1:10PM Q&A Facilitator: Mark Guttman (Canada)
1:10PM – 2:10PM LUNCH
2:10PM PANEL - Multidisciplinary
teams Introduction: Ruth Hagestuen (USA)
How are these approaches and models different?
What strengths do they offer or weakness do they create?
How do each of these models solve the problem of an individualized approach to care? Or do they?
[20 minute talk + Q&A immediately following each talk]
- 2:15PM Israeli Model - Tel Aviv Nir
- 2:45PM Netherlands Model – ParkinsonNet Marten
- 3:15PM US Model - Struthers Center Ruth
- 3:45PM Australian
- 4:15PM Canadian Model - McGill Movement Disorders Clinic Anne-Louise Lafontaine (Canada)
4:45PM - 5:10PM Q&A from all panelists & audience Bastiaan Bloem, (Netherlands) & Peter Fletcher (UK)
5:10PM - 5:30PM Wrap-up Alice Templin (Canada) & Nir Giladi (Israel)
Pre-congress Session III : Science & Advocacy
Target Audience: These will be crosstalk sessions appropriate for a
mix of the community, including clinicians, researchers, people with
Parkinson’s and others.
participants to unique research being carried out, advocacy programs being run
and others issues related to advancing the understanding of Parkinson’s science
and increasing involvement of people living with Parkinson’s in the process.
- To gain a more elaborate understanding of specific
research being done to advance the understanding of Parkinson’s;
- To learn about the ongoing efforts of community
members to advance advocacy and engage more people with Parkinson’s in the
clinical trial process;
- To understand future therapies for Parkinson’s.
Individual sessions are currently being designed and scheduled. More details to follow.
Sessions to be offered
Michael J. Fox Foundation for Parkinson’s Research
Parkinson’s Disease Foundation